News Articles Tagged: Addiction Medicine

The Journey of Varenicline Tartrate: From Discovery to Essential Medicine for Smoking Cessation

Trace the development of Varenicline tartrate, its classification as an essential medicine, and its impact on global smoking cessation efforts. NINGBO INNO PHARMCHEM CO.,LTD. explains its significance.

Advancing Cannabis Use Disorder Treatment: The Promise of AEF0117

Discover how AEF0117, a novel CB1-SSi, is showing promise in the treatment of Cannabis Use Disorder (CUD). Insights from research and development supported by NINGBO INNO PHARMCHEM CO.,LTD.

Clinical Trials of AEF0117: A Promising Development for Cannabis Use Disorder

An in-depth look at the clinical trial data for AEF0117, a novel CB1 receptor signaling-specific inhibitor, and its implications for treating Cannabis Use Disorder (CUD). Presented by NINGBO INNO PHARMCHEM CO.,LTD., this analysis covers Phase 1 and 2a results.